NurOwn (MSC-NTF) phase 2 clinical trial in progressive MS: effects on CSF neuroprotective biomarkers
MULTIPLE SCLEROSIS JOURNAL（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined